The role of management in lean implementation: evidence from the pharmaceutical industry

Sven Januszek,Julian Macuvele,Thomas Friedli,Torbjørn H. Netland

DOI: https://doi.org/10.1108/ijopm-02-2022-0129

2022-11-20

Abstract:Purpose The purpose of this study is to investigate how soft lean practices moderate the performance effects of hard lean practices. The authors provide new evidence from the pharmaceutical industry, which is characterized by a highly regulated and technical environment and has been largely uncharted in the lean literature. Design/methodology/approach Based on a review of the literature, the authors define a set of soft and hard lean practices. The authors test the hypotheses using factor analysis and moderated hierarchical linear regression on a unique dataset containing survey data and real performance measures of 351 pharmaceutical plants. Findings The results show that soft lean practices can be both enabling and constraining. When management engages in performance measurement, visualisation and employee empowerment the relationship between hard lean practices and performance is positively moderated. On the other hand, when managers emphasise goal setting and work standardisation the performance outcomes are reduced. Practical implications Effective lean managers build organisational commitment by motivating other employees to implement lean. They use performance measurement, visualisation and employee empowerment to focus on the "why". Less effective managers engage in commanding and micro-management. Such managers focus on the "what" by using practices like goal setting and work standardisation. Originality/value This article contributes to the literature on lean management by empirically testing the moderator-variable interaction effects between soft and hard lean practices. In addition, it adds new evidence from the important pharmaceutical industry.

management